Gefcy 250 Tablet

Gefcy 250 Tablet is primarily prescribed for cancer treatment. It functions by targeting epidermal growth factor receptor (EGFR) found in both normal and cancer cells, disrupting signals essential for cancer cell growth.

Gefitinib falls under the category of cancer medications and is utilized to treat specific types of cancers by inhibiting cancer cell growth. It targets the epidermal growth factor receptor (EGFR), present in both healthy and cancerous cells. By hindering specific proteins related to this receptor, Gefitinib interrupts the communication pathways crucial for cancer cell growth and survival Essentially, it halts the uncontrollable growth of cancer cells.

Follow the prescribed dose and duration as directed by your doctor. You can take this medicine with or without food but maintaining a consistent daily time is recommended for optimal results.

Common side effects may include diarrhea, dry skin, loss of appetite, nausea, rash, stomatitis (mouth inflammation), vomiting, weakness, and weight loss.

It has been associated with an increased risk of interstitial lung disease, a serious condition. Patients should be monitored for symptoms such as cough, difficulty breathing, and fever. Prompt medical attention is necessary if these symptoms occur, and treatment may need to be interrupted or discontinued.

If a dose is missed, take it when remembered. However, if the next dose is approaching, skip the missed one and continue with the regular dosing schedule. Avoid doubling doses. Consult your doctor for guidance on managing missed doses effectively.